Former director (through FY2025) · Kyverna Therapeutics, Inc. (KYTX)

Steve Liapis, Ph.D director compensation at Kyverna Therapeutics: $0

Fiscal year 2025 director compensation for Steve Liapis, Ph.D at Kyverna Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 13, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Steve Liapis, Ph.D’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Steve Liapis, Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Kyverna Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as Kyverna Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$0$0$0$0
FY2024$0—$0$0$0

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kyverna Therapeutics, Inc. DEF 14A filed April 13, 2026, accession 0001193125-26-152835, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Kyverna Therapeutics, Inc. filed document, accession 0001193125-26-152835. Every figure is read from that document and cited to the page and table it appears in. Filed April 13, 2026.

Get the Kyverna Therapeutics Board Governance Report

$0 Steve Liapis, Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 13, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Kyverna Therapeutics pays directors a $40,000 cash retainer and $175,000 in equity.

The rest of the Kyverna Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Andrew Miller, Ph.DIndependent Director—
Beth Seidenberg, M.DIndependent Director$242,452
Christi ShawChair of the Board$319,892
Daniel K. SpiegelmanIndependent Director$234,952
Fred E. Cohen, M.D., D.PhilIndependent Director$237,452
Ian ClarkIndependent Director$259,952
Mert AktarIndependent Director$232,452
Sravan EmanyIndependent Director—
Warner BiddleDirector—

The full Kyverna Therapeutics compensation record

free company brief

This page is one director within Kyverna Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order KYTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report